Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
INBX
Stock Latest News
Company Announcements
Inhibrx Biosciences BLA Accepted for Ozekibart Chondrosarcoma Therapy
14d ago
8K
INBX
Premium
The Fly
Inhibrx announces FDA acceptance of BLA for ozekibart
14d ago
INBX
Premium
Company Announcements
Inhibrx Biosciences Holds 2026 Virtual Annual Shareholder Meeting
26d ago
8K
INBX
Premium
The Fly
Inhibrx price target raised to $325 from $300 at Stifel
2M ago
INBX
Premium
The Fly
Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year
2M ago
INBX
Premium
Company Announcements
Inhibrx Biosciences Reports Positive Interim Phase 2 Results
2M ago
8K
INBX
Premium
The Fly
Inhibrx’s INBRX-106 shows potential benefit in HNSCC
2M ago
INBX
Premium
The Fly
Inhibrx initiated with an Outperform at LifeSci Capital
2M ago
INBX
Premium
The Fly
Inhibrx price target raised to $300 from $150 at Stifel
2M ago
INBX
Premium
The Fly
Midday Fly By: Boeing, AT&T report Q1 beats
2M ago
T
BA
Premium
The Fly
Inhibrx trading halted, volatility trading pause
2M ago
INBX
Premium
The Fly
Inhibrx trading resumes
2M ago
INBX
Premium
The Fly
Inhibrx’s cancer drug drawing interest from Merck, Ono, Reuters says
2M ago
MRK
INBX
Premium
The Fly
Inhibrx up 39% at $117 after report of interest from Merck in cancer assets
2M ago
INBX
Premium
Company Announcements
Inhibrx Biosciences Highlights Promising Ozekibart Colorectal Cancer Data
2M ago
8K
INBX
Premium
The Fly
Inhibrx reports interim data from its Phase 1/2 study evaluating ozekibart
2M ago
INBX
Premium
The Fly
Coinbase downgraded, Deere upgraded: Wall Street’s top analyst calls
3M ago
DE
GD
Premium
The Fly
Inhibrx initiated with a Buy at Stifel
3M ago
INBX
Premium
The Fly
Inhibrx reports Q4 EPS ($2.11) vs. ($3.09) last year
3M ago
INBX
Premium
Company Announcements
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy
4M ago
8K
INBX
Premium
Company Announcements
Inhibrx Biosciences Updates on Clinical Trials Progress
6M ago
8K
INBX
Premium
The Fly
Inhibrx provides update on INBRX-106 Phase 2/3 clinical trial
6M ago
INBX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
